HIV Research for Prevention (HIV R4P) 2024

October 6-10, 2024, Lima, Peru

Peet M, Agrahari V, Chandra N, Forsback A-P, Akieh-Pirkanniemi M, Leino L, Kaushal G, Doncel G, Clark M. Development of a long-acting biodegradable hydrogel injectable system for single or multi-purpose prevention of HIV and/or pregnancy. HIV R4P 2024. Abstract #OA0206 (Oral Presentation) 

Bozzani FM, Torres-Rueda S, Desai K, Mukora R, Anzala O, Mabunda H, Kenei C, Chuma B, Dawa J,Omondi DR, Mhembere T, Katumba KR, Chapman K, Gafos M, Medley G, Gomez G. Future delivery pathways and costs for next generation HIV and pregnancy prevention products: exploratory analyses to inform early product development. HIV R4P 2024. Abstract #TUPE076 (Poster) 

Maenetje P, Su C, Longwe M, Tirop LJ, Legoabe L, Hayeshi R, Heffron R, Mugo N, Owidi E, Mamvura T, Mgodi N, Verbitski S, Holt BY, Hillier SL, Palanee-Phillips T. Efforts to enhance capacity in early HIV and pregnancy prevention product development research in East and Southern Africa. HIV R4P 2024. Abstract #TUPE031 (Poster)

Barnable P, Visciano ML, Aravantinou M, Kommineni N, Gadsden J, Schiro F, Guzmán L, Grasperge B, Angsantikul P, Fernandez-Romero J, Haddad LB, Teleshova N. Safety/pharmacokinetics/pharmacodynamics and immunogenicity studies of griffithsin fast dissolving insert in rhesus macaques. HIV R4P 2024, Lima, Peru. Abstract #WEPE018 (Poster)